Comphya SA raised CHF 7.5 million (US$ 8.4 million) in a series A round for its implantable neurostimulation therapy, Caverstim, which treats men with erectile dysfunction who do not respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback